A nutritionist reviews the new ready-to-eat, high-protein Factor x Sakara salads with a focus on nutrition, flavor, texture, ...
Researchers assessed whether combination mosunetuzumab and polatuzumab vedotin would reduce the risk of disease progression or death in patients with LBCL.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback